On February 12, 2024, Skye Bioscience, Inc., closed the transaction. The company has raised $49,991,010 from 11 investors. The company paid sales commission of $3,499,371 in the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13 USD | +1.64% | +1.17% | +377.94% |
Apr. 23 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Transportation Index | CI |
Apr. 12 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Composite Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+377.94% | 359M | |
+25.73% | 42.68B | |
-3.00% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.53% | 24.94B | |
-20.12% | 18.96B | |
+28.96% | 12.3B | |
-2.72% | 11.95B | |
-1.50% | 11.55B |
- Stock Market
- Equities
- EMBI Stock
- News Skye Bioscience, Inc.
- Skye Bioscience, Inc. announced that it has received $49.99101 million in funding